简体
简体中文
繁體中文

FTI咨询 FCN

已收盘 11-26 16:00:00 美东时间

163.95

-1.550

-0.94%

华盛通华盛通
立即下载
  • 最 高166.625
  • 今 开165.04
  • 成交量 24.57万股
  • 最 低 163.95
  • 昨 收 165.50
  • 总市值 50.62亿
  • 52周最高 204.76
  • 市盈率 20.98
  • 换手率 0.80%
  • 52周最低 149.31
  • 委 比 78.57%
  • 总股本 3087.61万
  • 历史最高 243.60
  • 量 比 0.92
  • 振 幅 1.62%
  • 历史最低 22.88
  • 每 手 1
  • 风险率 13.75%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • FTI Consulting Signs New London Office Lease Agreement

    The latest announcement is out from FTI Consulting ( ($FCN) ). On November 21, ...

    今天 05:59

  • Diversified Energy Completes Canvas Energy Acquisition

    Diversified Energy completes the acquisition of Canvas Energy for ~$550 million, adding ~147 MMcfepd production and 1.6 million net acres in Oklahoma. The deal includes $400 million ABS financing and issuance of 3.7 million shares. The transaction is expected to generate significant synergies and enhance operational efficiency.

    11-24 15:30

  • Final Approval of The Scheme of Arrangement

    Diversified Energy Company is restructuring to become a Delaware-incorporated company, with the NYSE as its primary listing and retaining a secondary listing on the LSE. The scheme was approved by the High Court, and the changes will take effect on November 24, 2025. The company will continue its share buyback program as previously announced.

    11-21 15:30

  • Publication of a Prospectus

    Diversified Energy Company has announced the approval of its prospectus by the FCA for the listing of its ordinary shares on the London Stock Exchange. The prospectus is available on the company's website and via the National Storage Mechanism. The scheme is expected to become effective on November 21, 2025, with shares listing on the NYSE and LSE on November 24, 2025. For more details, visit the Investor Relations section or contact the listed r...

    11-19 12:41

  • EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

    EyePoint Pharmaceuticals announced that the Data Safety Monitoring Committee (DSMC) recommended continuing its Phase 3 LUGANO and LUCIA trials for DURAVYU as planned, with no protocol changes needed. The safety data remains consistent with prior trials, showing no safety signals. All patients have received their initial dose, and 25% have received their second dose. DURAVYU is being evaluated for wet age-related macular degeneration (wet AMD), wi...

    11-19 12:00

  • Best AI productivity beneficiary stocks - Goldman

    Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...

    11-18 21:52

  • EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    EyePoint Pharmaceuticals granted 7 new employees non-statutory stock options to purchase up to 31,000 shares under NASDAQ Listing Rule 5635(c)(4). The options, with an exercise price of $11.58, vest over four years and have a 10-year term. EyePoint focuses on developing therapeutics for serious retinal diseases, with its lead candidate DURAVYU in Phase 3 trials for wet AMD and DME.

    11-17 12:00

  • Diversified Energy Results of the Court Meeting and General Meeting

    On November 10, 2025, Diversified Energy Company PLC held key meetings to approve a proposed scheme to establish a new Delaware corporation as its parent holding company. The court meeting, which required at least a 75% majority, saw 99.35% of shareholders approve the scheme. The general meeting also passed all resolutions, including the 2025 Equity Incentive Plan (94.83% approval) and special resolutions (99.72% approval). The scheme remains sub...

    11-10 16:30

  • FTI Consulting Continues Investment in EMEA Tax Capabilities with Addition of Two Senior Hires

    FTI Consulting has bolstered its EMEA Tax Advisory team with the addition of two senior experts: Marcus Rea as Senior Managing Director and Thomas Lassey as Managing Director. Rea, based in London, brings over 25 years of experience advising on tax aspects of complex transactions, while Lassey, based in Dubai, has 13 years of expertise in tax compliance and advisory services. Their expertise strengthens FTI Consulting's ability to support clients...

    11-10 08:00

  • 谷歌、英伟达开始将算力运上太空

    专题:弱美元周期叠加内需改善 A股中期慢牛格局动力夯实   炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!  ...

    11-07 08:30